Selected research
Industry Research
Legal Surrogacy Industry Research Report 2026
Market perspective
The global Legal Surrogacy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Legal Surrogacy market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Legal Surrogacy market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Legal Surrogacy market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Legal Surrogacy include New Hope Fertility Center, IVI-RMA Global, Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions and Cardone & Associates Reproductive Medicine & Infertility, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Legal Surrogacy market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Legal Surrogacy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Legal Surrogacy Market by Company
New Hope Fertility Center
IVI-RMA Global
Scanfert AVA Clinic
Bourn Hall Fertility Clinic
Nova IVI Fertility
Ovation Fertility
Bangkok IVF Center
Extraordinary Conceptions
Cardone & Associates Reproductive Medicine & Infertility
Max Healthcare
Growing Generations
Circle Surrogacy
Morpheus Life Sciences
Legal Surrogacy Segment by Type
Intrauterine Insemination (IUI)
In-vitro Fertilization (IVF)
Others
Legal Surrogacy Segment by Application
Below 35 Years
35-45 Years
Over 45 Years
Legal Surrogacy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Legal Surrogacy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Legal Surrogacy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Legal Surrogacy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Legal Surrogacy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Intrauterine Insemination (IUI)
- In-vitro Fertilization (IVF)
- Others
Applications
- Below 35 Years
- 35-45 Years
- Over 45 Years
Companies covered
- New Hope Fertility Center
- IVI-RMA Global
- Scanfert AVA Clinic
- Bourn Hall Fertility Clinic
- Nova IVI Fertility
- Ovation Fertility
- Bangkok IVF Center
- Extraordinary Conceptions
- Cardone & Associates Reproductive Medicine & Infertility
- Max Healthcare
- Growing Generations
- Circle Surrogacy
- Morpheus Life Sciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Legal Surrogacy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Intrauterine Insemination (IUI)
- 2.2.3 In-vitro Fertilization (IVF)
- 2.2.4 Others
- 2.3 Legal Surrogacy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Below 35 Years
- 2.3.3 35-45 Years
- 2.3.4 Over 45 Years
- 2.4 Assumptions and Limitations
3 Legal Surrogacy Breakdown Data by Type
- 3.1 Global Legal Surrogacy Historic Market Size by Type (2021-2026)
- 3.2 Global Legal Surrogacy Forecasted Market Size by Type (2027-2032)
4 Legal Surrogacy Breakdown Data by Application
- 4.1 Global Legal Surrogacy Historic Market Size by Application (2021-2026)
- 4.2 Global Legal Surrogacy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Legal Surrogacy Market Perspective (2021-2032)
- 5.2 Global Legal Surrogacy Growth Trends by Region
- 5.2.1 Global Legal Surrogacy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Legal Surrogacy Historic Market Size by Region (2021-2026)
- 5.2.3 Legal Surrogacy Forecasted Market Size by Region (2027-2032)
- 5.3 Legal Surrogacy Market Dynamics
- 5.3.1 Legal Surrogacy Industry Trends
- 5.3.2 Legal Surrogacy Market Drivers
- 5.3.3 Legal Surrogacy Market Challenges
- 5.3.4 Legal Surrogacy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Legal Surrogacy Players by Revenue
- 6.1.1 Global Top Legal Surrogacy Players by Revenue (2021-2026)
- 6.1.2 Global Legal Surrogacy Revenue Market Share by Players (2021-2026)
- 6.2 Global Legal Surrogacy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Legal Surrogacy Head Office and Area Served
- 6.4 Global Legal Surrogacy Players, Product Type & Application
- 6.5 Global Legal Surrogacy Manufacturers Established Date
- 6.6 Global Legal Surrogacy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Legal Surrogacy Market Size (2021-2032)
- 7.2 North America Legal Surrogacy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Legal Surrogacy Market Size by Country (2021-2026)
- 7.4 North America Legal Surrogacy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Legal Surrogacy Market Size (2021-2032)
- 8.2 Europe Legal Surrogacy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Legal Surrogacy Market Size by Country (2021-2026)
- 8.4 Europe Legal Surrogacy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Legal Surrogacy Market Size (2021-2032)
- 9.2 Asia-Pacific Legal Surrogacy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Legal Surrogacy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Legal Surrogacy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Legal Surrogacy Market Size (2021-2032)
- 10.2 South America Legal Surrogacy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Legal Surrogacy Market Size by Country (2021-2026)
- 10.4 South America Legal Surrogacy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Legal Surrogacy Market Size (2021-2032)
- 11.2 Middle East & Africa Legal Surrogacy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Legal Surrogacy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Legal Surrogacy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 New Hope Fertility Center
- 12.1.1 New Hope Fertility Center Company Information
- 12.1.2 New Hope Fertility Center Business Overview
- 12.1.3 New Hope Fertility Center Revenue in Legal Surrogacy Business (2021-2026)
- 12.1.4 New Hope Fertility Center Legal Surrogacy Product Portfolio
- 12.1.5 New Hope Fertility Center Recent Developments
- 12.2 IVI-RMA Global
- 12.2.1 IVI-RMA Global Company Information
- 12.2.2 IVI-RMA Global Business Overview
- 12.2.3 IVI-RMA Global Revenue in Legal Surrogacy Business (2021-2026)
- 12.2.4 IVI-RMA Global Legal Surrogacy Product Portfolio
- 12.2.5 IVI-RMA Global Recent Developments
- 12.3 Scanfert AVA Clinic
- 12.3.1 Scanfert AVA Clinic Company Information
- 12.3.2 Scanfert AVA Clinic Business Overview
- 12.3.3 Scanfert AVA Clinic Revenue in Legal Surrogacy Business (2021-2026)
- 12.3.4 Scanfert AVA Clinic Legal Surrogacy Product Portfolio
- 12.3.5 Scanfert AVA Clinic Recent Developments
- 12.4 Bourn Hall Fertility Clinic
- 12.4.1 Bourn Hall Fertility Clinic Company Information
- 12.4.2 Bourn Hall Fertility Clinic Business Overview
- 12.4.3 Bourn Hall Fertility Clinic Revenue in Legal Surrogacy Business (2021-2026)
- 12.4.4 Bourn Hall Fertility Clinic Legal Surrogacy Product Portfolio
- 12.4.5 Bourn Hall Fertility Clinic Recent Developments
- 12.5 Nova IVI Fertility
- 12.5.1 Nova IVI Fertility Company Information
- 12.5.2 Nova IVI Fertility Business Overview
- 12.5.3 Nova IVI Fertility Revenue in Legal Surrogacy Business (2021-2026)
- 12.5.4 Nova IVI Fertility Legal Surrogacy Product Portfolio
- 12.5.5 Nova IVI Fertility Recent Developments
- 12.6 Ovation Fertility
- 12.6.1 Ovation Fertility Company Information
- 12.6.2 Ovation Fertility Business Overview
- 12.6.3 Ovation Fertility Revenue in Legal Surrogacy Business (2021-2026)
- 12.6.4 Ovation Fertility Legal Surrogacy Product Portfolio
- 12.6.5 Ovation Fertility Recent Developments
- 12.7 Bangkok IVF Center
- 12.7.1 Bangkok IVF Center Company Information
- 12.7.2 Bangkok IVF Center Business Overview
- 12.7.3 Bangkok IVF Center Revenue in Legal Surrogacy Business (2021-2026)
- 12.7.4 Bangkok IVF Center Legal Surrogacy Product Portfolio
- 12.7.5 Bangkok IVF Center Recent Developments
- 12.8 Extraordinary Conceptions
- 12.8.1 Extraordinary Conceptions Company Information
- 12.8.2 Extraordinary Conceptions Business Overview
- 12.8.3 Extraordinary Conceptions Revenue in Legal Surrogacy Business (2021-2026)
- 12.8.4 Extraordinary Conceptions Legal Surrogacy Product Portfolio
- 12.8.5 Extraordinary Conceptions Recent Developments
- 12.9 Cardone & Associates Reproductive Medicine & Infertility
- 12.9.1 Cardone & Associates Reproductive Medicine & Infertility Company Information
- 12.9.2 Cardone & Associates Reproductive Medicine & Infertility Business Overview
- 12.9.3 Cardone & Associates Reproductive Medicine & Infertility Revenue in Legal Surrogacy Business (2021-2026)
- 12.9.4 Cardone & Associates Reproductive Medicine & Infertility Legal Surrogacy Product Portfolio
- 12.9.5 Cardone & Associates Reproductive Medicine & Infertility Recent Developments
- 12.10 Max Healthcare
- 12.10.1 Max Healthcare Company Information
- 12.10.2 Max Healthcare Business Overview
- 12.10.3 Max Healthcare Revenue in Legal Surrogacy Business (2021-2026)
- 12.10.4 Max Healthcare Legal Surrogacy Product Portfolio
- 12.10.5 Max Healthcare Recent Developments
- 12.11 Growing Generations
- 12.11.1 Growing Generations Company Information
- 12.11.2 Growing Generations Business Overview
- 12.11.3 Growing Generations Revenue in Legal Surrogacy Business (2021-2026)
- 12.11.4 Growing Generations Legal Surrogacy Product Portfolio
- 12.11.5 Growing Generations Recent Developments
- 12.12 Circle Surrogacy
- 12.12.1 Circle Surrogacy Company Information
- 12.12.2 Circle Surrogacy Business Overview
- 12.12.3 Circle Surrogacy Revenue in Legal Surrogacy Business (2021-2026)
- 12.12.4 Circle Surrogacy Legal Surrogacy Product Portfolio
- 12.12.5 Circle Surrogacy Recent Developments
- 12.13 Morpheus Life Sciences
- 12.13.1 Morpheus Life Sciences Company Information
- 12.13.2 Morpheus Life Sciences Business Overview
- 12.13.3 Morpheus Life Sciences Revenue in Legal Surrogacy Business (2021-2026)
- 12.13.4 Morpheus Life Sciences Legal Surrogacy Product Portfolio
- 12.13.5 Morpheus Life Sciences Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst